CRBU (Caribou Biosciences, Inc. Common Stock) Stock Analysis - Community
Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of May 21, 2026, CRBU trades at $2.01 with a market cap of $205.30M and a P/E ratio of -1.24. CRBU moved +0.76% today. Year to date, CRBU is +24.22%; over the trailing twelve months it is +81.82%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade CRBU?
Rallies community data for CRBU shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Rallies community data for CRBU shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CRBU?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CRBU when enough community data is available.
Is CRBU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CRBU. It does not provide personalized investment advice.